Skip to search boxSkip to navigationSkip to main content

Antimicrobial activity of curcumin in nanoformulations: A comprehensive review

  • Jeffersson Krishan Trigo‐gutierrez
    ,
  • ,
  • Amanda Brandão Soares
    ,
  • Ewerton Garcia de Oliveira Mima(corresponding author)
*Corresponding author for this work
  • São Paulo State University (UNESP)
    ,
  • Laboratory of Applied Microbiology
Research Output:
Contribution to journal
Review article
Peer-review

Open access

Publication Information

Output type

Research Output:
Contribution to journal
Review article
Peer-review

Original language

English

Article number

7130

Journal (Volume, Issue Number)

International Journal of Molecular Sciences (Volume 22, Issue 13)

Publication milestones

  • Published - 01/07/2021

Publication status

Published - 01/07/2021

ISSN

1661-6596

Publication IDs

  • Scopus: 85108943382
  • PubMed: 34281181

Abstract

Curcumin (CUR) is a natural substance extracted from turmeric that has antimicrobial properties. Due to its ability to absorb light in the blue spectrum, CUR is also used as a photosen-sitizer (PS) in antimicrobial Photodynamic Therapy (aPDT). However, CUR is hydrophobic, un-stable in solutions, and has low bioavailability, which hinders its clinical use. To circumvent these drawbacks, drug delivery systems (DDSs) have been used. In this review, we summarize the DDSs used to carry CUR and their antimicrobial effect against viruses, bacteria, and fungi, including drug‐resistant strains and emergent pathogens such as SARS‐CoV‐2. The reviewed DDSs include colloidal (micelles, liposomes, nanoemulsions, cyclodextrins, chitosan, and other polymeric nano-particles), metallic, and mesoporous particles, as well as graphene, quantum dots, and hybrid nanosystems such as films and hydrogels. Free (non‐encapsulated) CUR and CUR loaded in DDSs have a broad‐spectrum antimicrobial action when used alone or as a PS in aPDT. They also show low cytotoxicity, in vivo biocompatibility, and improved wound healing. Although there are several in vitro and some in vivo investigations describing the nanotechnological aspects and the potential antimicrobial application of CUR‐loaded DDSs, clinical trials are not reported and further studies should translate this evidence to the clinical scenarios of infections.

Publication metrics

Metrics

Scopus
citations

PlumX, opens in new tab

Citation count
151
Captures
362